Internal Medicine, Endocrinology, Diabetes, & Metabolism · Hanover, PA
NPI
1497737928
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2201 Brunswick Dr Ste 2300
Hanover, PA, 17331
Phone (717) 316-3670
Groups this clinician bills Medicare through
Medicare paid, 2024
$165K
4,273 services
Medicare patients, 2024
650
Average age 74
Drug cost, 2024
$3.8M
7,356 prescriptions
Company payments, 2024
$13K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James A Dicke was code J0897 (injection, denosumab, 1 mg), 2,280 times for 22 patients. In total James A Dicke billed 4,273 services in 24 codes, and Medicare paid $165K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,280 | 22 | $20.59 | $47K |
| 99214 Office E&M - Established | Office | 1,081 | 564 | $87.13 | $94K |
| 83036 Blood Count | Office | 467 | 284 | $9.43 | $4,403 |
| 99211 Office E&M - Established | Office | 127 | 74 | $15.59 | $1,980 |
| 95251 Test - Miscellaneous | Office | 122 | 89 | $26.39 | $3,220 |
| 96372 Injection Administration | Office | 70 | 28 | $9.19 | $643 |
| 99215 Office E&M - Established | Office | 40 | 38 | $129.79 | $5,191 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 14 | $12.56 | $176 |
| 99443 Telephone Services | Office | 12 | 11 | $89.25 | $1,071 |
By year: 2022 $157K for 4,256 services; 2023 $152K for 4,040 services; 2024 $165K for 4,273 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 467 | 284 | $9.43 | $4,403 |
Medicare prescription drug claims, 2024
In 2024, the drug James A Dicke prescribed most often to Medicare patients was Levothyroxine Sodium, with 685 prescriptions and refills. In total James A Dicke wrote 7,356 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 685 | 1,684 | 174 | $7,271 |
| Ozempic Semaglutide | 522 | 936 | 120 | $896K |
| Tresiba Flextouch U-200 Insulin Degludec | 389 | 945 | 115 | $634K |
| Farxiga Dapagliflozin Propanediol | 301 | 631 | 73 | $346K |
| Synthroid Levothyroxine Sodium | 227 | 643 | 57 | $22K |
| Tresiba Flextouch U-100 Insulin Degludec | 207 | 471 | 63 | $144K |
| Novolog Flexpen Insulin Aspart | 197 | 487 | 79 | $70K |
| Metformin Hcl Er Metformin Hcl | 196 | 557 | 59 | $2,512 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 194 | 541 | 76 | $22K |
| Metformin Hcl Generic | 149 | 403 | 43 | $1,260 |
| Jardiance Empagliflozin | 131 | 240 | 33 | $132K |
| Rosuvastatin Calcium Generic | 114 | 312 | 31 | $2,452 |
| Mounjaro Tirzepatide | 107 | 140 | 18 | $149K |
| Gabapentin Generic | 106 | 238 | 34 | $2,318 |
| Humalog Kwikpen U-100 Insulin Lispro | 100 | 225 | 37 | $32K |
Brand drugs: 3,451 claims; generic drugs: 3,467 claims; opioid claims: 80.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid James A Dicke $13K ($13K in general payments such as food, travel and fees) from 2 companies. The largest payer was Novo Nordisk Inc with $9,069.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.